Doha, Qatar
The National Center for Cancer Care and Research (NCCCR) at Hamad Medical Corporation (HMC) has emerged as a premier destination for cancer treatment in the Gulf. Patients from across the region seek its advanced technology, personalized treatment plans, and expert multidisciplinary team. This reinforces its reputation for excellence.
Dr. Mohamed Salem Al-Hassan, Medical Director and CEO of NCCCR and Chair of Corporate Cancer Services at HMC, emphasized the center’s growing regional recognition.
“NCCCR is known for its outstanding quality of care and innovative treatments. Patients choose us for access to cutting-edge therapies and state-of-the-art facilities. They also appreciate our holistic, patient-centered approach. In 2024, we treated 508 international patients from the region. Our combination of expertise, advanced technology, and compassionate care has made us the preferred choice for many patients from the GCC and beyond.”
He further highlighted HMC’s leadership in cancer treatment, offering procedures often unavailable elsewhere in the region.
“Our capabilities range from robotic-assisted surgery and precision medicine to breakthrough target hormone and immunotherapies. This ensures the best possible outcomes for our patients. While we welcome international patients seeking specialized care, our primary focus remains on serving the people of Qatar. This ensures they receive world-class treatment without having to travel abroad.”
NCCCR provides comprehensive cancer care, including Bone Marrow Transplants, advanced Radiation Oncology with TrueBeam, ETHOS, and CyberKnife technologies, and genetic counseling for hereditary cancer risks. The center also prioritizes mental health, offering psychotherapy services to support patients throughout their treatment.
As a leader in oncology, NCCCR remains committed to advancing cancer care through innovation, research, and continuous improvements. This ensures both Qatar’s local population and international patients receive the highest standard of treatment in the region.
